Status:
COMPLETED
A COVID-19 Symptom, Exposure and Immune Response Registry
Lead Sponsor:
ObvioHealth
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
This is a 6-month, 100% remote study that will collect a broad range of data that may provide insight into the COVID-19 global pandemic. Data collected will include participant medical histories, hist...
Detailed Description
This is a 6-month, 100% remote study that will collect a broad range of data that may provide insight into the COVID-19 global pandemic. All data will be collected by participant entry into a mobile a...
Eligibility Criteria
Inclusion
- Open to any adult individuals (18 years of age or older) permanently residing in the United States
- Have regular access to smartphone and internet sufficient to support registry demands
- Willing and able to follow the procedures of the study
- Willing and able to provide informed consent
Exclusion
- Participants unable to understand the study protocol or provide informed consent
- Participants unable or unwilling to perform all requested study tasks
Key Trial Info
Start Date :
May 29 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 21 2021
Estimated Enrollment :
804 Patients enrolled
Trial Details
Trial ID
NCT04348942
Start Date
May 29 2020
End Date
March 21 2021
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ObvioHealth
Orlando, Florida, United States, 328017